NCT02813577View on ClinicalTrials.gov

Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries in United States Females (CONFIRM)

NATerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

April 20, 2018

Primary Completion Date

February 18, 2019

Study Completion Date

February 18, 2019

Conditions
Femoral Artery StenosisPopliteal Artery StenosisFemoral Artery OcclusionPopliteal Artery Occlusion
Interventions
DEVICE

Lutonix® 035 Drug Coated Balloon PTA Catheter

Female subjects will receive the Lutonix® 035 Drug Coated Balloon PTA Catheter.

Trial Locations (4)

29118

Vascular Access Solutions, Orangeburg

37660

Wellmont CVA Heart Institute, Kingsport

46290

St. Vincent Medical Group, Indianapolis

52803

Midwest Cardiovascular Research Foundation, Davenport

Sponsors

Lead Sponsor

C. R. Bard
All Listed Sponsors
lead

C. R. Bard

INDUSTRY

NCT02813577 - Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries in United States Females (CONFIRM) | Biotech Hunter | Biotech Hunter